- PR Newswire•4 days ago
LAWRENCE, Mass., Feb. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that Jeffrey H. Burbank, Founder ...
- PR Newswire•17 days ago
In this new position, Collins will lead a new Medical Affairs team in addition to continuing his current role as chair of the Company's Scientific Advisory Board. "I'm excited to continue integrating medical insights with a robust dataset to engage key opinion leaders and expand patient access to NxStage's life-changing therapies," stated Dr. Collins.
- Capital Cube•26 days agoNxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : January 25, 2017
Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for NxStage Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)
NXTM : Summary for NxStage Medical, Inc. - Yahoo Finance
Nxstage Medical, Inc. (NXTM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||29.12 - 29.99|
|52 Week Range||13.49 - 29.99|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-322.69|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|